Wide Ranks

DNA

Ginkgo Bioworks Holdings, Inc.

8.26

Top Statistics
Market Cap 474 M Forward PE -1.04 Revenue Growth 60.60 %
Current Ratio 5.79 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -298.78 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -0.5310 Enterprise / Revenue 1.28 Price To Sales Trailing12 Months 2.18
Profitability
Profit Margins -298.78 % Operating Margins -58.68 %
Balance Sheet
Total Cash 616 M Total Cash Per Share 11.31 Total Debt 445 M
Total Debt To Equity 55.84 Current Ratio 5.79 Book Value Per Share 14.65
All Measures
Short Ratio 657.00 % Message Board Id finmb_130407341 Shares Short Prior Month 7 M
Return On Equity -0.6351 City Boston Uuid 396c983d-4290-301e-8060-ffe25e7c0eb3
Previous Close 7.95 First Trade Date Epoch Utc 1 B Book Value 14.65
Total Debt 445 M Volume 542861 Price To Book 0.5639
Last Split Date 1 B Fifty Two Week Low 5.26 Total Cash Per Share 11.31
Total Revenue 217 M Shares Short Previous Month Date 1 B Target Median Price 8.00
Max Age 86400 Recommendation Mean 3.50 Sand P52 Week Change 0.3133
Operating Margins -58.68 % Target Mean Price 8.20 Net Income To Common -651188992
Ask 8.30 Short Percent Of Float 0.2198 Implied Shares Outstanding 57 M
Last Fiscal Year End 1 B Trailing Peg Ratio None Average Daily Volume10 Day 1 M
Average Volume10days 1 M Total Cash 616 M Next Fiscal Year End 1 B
Revenue Per Share 4.29 Held Percent Insiders 0.0616 Ebitda Margins -241.23 %
Trailing PE 0.0000 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 7.95 Target Low Price 6.00 Gmt Off Set Milliseconds -18000000
Fifty Day Average 7.92 Open 8.08 Free Cashflow -317241504
State MA Dividend Yield 0.00 % Return On Assets -0.2092
Time Zone Short Name EST Trailing Eps -12.89 Day Low 7.97
Address1 27 Drydock Avenue Shares Outstanding 45 M Price Hint 2
Target High Price 10.00 Website https://www.ginkgobioworks.com 52 Week Change -0.8399
Average Volume 1 M Forward Eps -7.97 Recommendation Key hold
Compensation As Of Epoch Date 1 B Quick Ratio 559.40 % Last Split Factor 1:40
Regular Market Day High 8.35 Is_sp_500 False Profit Margins -298.78 %
Debt To Equity 55.84 Fifty Two Week High 75.20 Day High 8.35
Shares Short 7 M Regular Market Open 8.08 Industry Key biotechnology
Bid 8.25 Earnings Growth 0.00 % Enterprise To Revenue 1.28
Revenue Growth 60.60 % Shares Percent Shares Out 0.1273 Operating Cashflow -334980992
Currency USD Time Zone Full Name America/New_York Market Cap 474 M
Is_nasdaq_100 False Zip 02210 Quote Type EQUITY
Industry Biotechnology Long Name Ginkgo Bioworks Holdings, Inc. Regular Market Day Low 7.97
Held Percent Institutions 0.6856 Current Price 8.26 Address2 8th Floor
Enterprise To Ebitda -0.5310 Financial Currency USD Current Ratio 5.79
Gross Margins 80.94 % Industry Disp Biotechnology Number Of Analyst Opinions 5
Country United States Float Shares 32 M Two Hundred Day Average 22.02
Enterprise Value 279 M Price To Sales Trailing12 Months 2.18 Forward PE -1.04
Regular Market Volume 542861 Ebitda -525771008 Exchange NYQ
Go to Yahoo Finance Go to Seeking Alpha 
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States.

Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum.

It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries.

Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.